Symptomatic benefit 1-3 years after H. pylori eradication in ulcer patients: Impact of gastroesophageal reflux disease

American Journal of Gastroenterology

Volumn 95, Issue 1, 2000, Pages 101-105

  McColl, Kenneth E L ^a   Dickson, Anthea ^a   El Nujumi, Adil ^a   El Omar, Emad ^a   Kelman, Andrew ^a  

^a WESTERN INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; METRONIDAZOLE; OMEPRAZOLE; STOMACH SECRETION INHIBITOR; TETRACYCLINE DERIVATIVE; UREA;

ADULT; AGED; ARTICLE; BREATH ANALYSIS; CONTINUING EDUCATION; DISEASE ASSOCIATION; DISEASE CONTROL; DISEASE SEVERITY; DUODENUM ULCER; DYSPEPSIA; ESOPHAGITIS; FEMALE; GASTROESOPHAGEAL REFLUX; GLASGOW COMA SCALE; HEARTBURN; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RECURRENT DISEASE; RISK ASSESSMENT; STATISTICAL ANALYSIS; STOMACH ULCER; TREATMENT PLANNING;

ADULT; AGED; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; DRUG THERAPY, COMBINATION; FEMALE; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; OMEPRAZOLE; PENICILLINS; PEPTIC ULCER;

EID: 0033987629     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(99)00765-0     Document Type: Article

References (32)

1. Marshall B.J., Goodwin C.S., Warren J.R., et al. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet. ii:1988;1437-1441.
2. Hentschel E., Brandstatter G., Dragosics B., et al. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med. 328:1993;308-312.
3. Labenz J., Borsch G. Evidence for the essential role of Helicobacter pylori in gastric ulcer disease. Gut. 35:1994;19-22.
4. Sung J.Y., Chung S.C., Ling T.K.W., et al. Antibacterial treatment of gastric ulcers associated with Helicobacter pylori. N Engl J Med. 332:1995;139-142.
5. Axon A.T.R., O'Morain C.A., Bardhan K.D., et al. Randomised double blind controlled study of recurrence of gastric ulcer after treatment for eradication of Helicobacter pylori infection. Br Med J. 314:1997;565-568.
6. Saberi-Firoozi M., Massarrat S., Zare S., et al. Effect of triple therapy or amoxycillin plus omeprazole or amoxycillin plus tinidazole plus omeprazole on duodenal ulcer healing, eradication of Helicobacter pylori, and prevention of ulcer relapse over a 1-year follow-up period A prospective, randomized, controlled study . Am J Gastroenterol. 90:1995;1419-1423.
7. McDonald A.J., Peden N.R., Hayton R., et al. Symptom relief and the placebo effect in the trial of an anti-peptic drug. Gut. 21:1980;323-326.
8. Burland W.L., Hawkins B.W., Beresford J. Cimetidine treatment for the prevention of recurrence of duodenal ulcer, an international collaborative study. Postgrad Med J. 56:1980;173-176.
9. McColl K.E.L., El-Nujumi A., Murray L., et al. The Helicobacter pylori breath test A surrogate marker for peptic ulcer disease in dyspeptic patients . Gut. 40:1997;302-306.
10. McColl KEL, Murray L, El-Omar E, et al. Symptomatic benefit from eradicating Helicobacter pylori infection in patients with non-ulcer dyspepsia. N Engl J Med 1998;339:26:1869-74.
11. El-Omar E.M., Banerjee S., Wirz A., et al. The Glasgow dyspepsia severity score - a tool for the global measurement of dyspepsia. Eur J Gastroenterol Hepatol. 8:1996;967-971.
12. McColl K.E.L., El-Nujumi A., Murray L.S., et al. Assessment of symptomatic response as predictor of Helicobacter pylori status following eradication therapy in patients with ulcer. Gut. 42:1998;618-622.
13. 14C-urea breath test in determining Helicobacter pylori status and predicting ulcer disease in dyspeptic patients. Am J Gastroenterol. 93:1998;20-25.
14. Labenz J. Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse. Digestion. 55:1994;19-23.
15. Graham D.Y., Hepps K.S., Ramirez F.C., et al. Treatment of Helicobacter pylori reduces the rate or rebleeding in peptic ulcer disease. Scand J Gastroenterol. 28:1993;939-942.
16. Jaspersen D., Koerner T., Schorr W., et al. Helicobacter pylori eradication reduces the rate of rebleeding in ulcer hemorrhage. Gastrointest Endosc. 41:1995;5-7.
17. Reilly T.G., Ayres R.C.S., Poxon V., et al. Helicobacter pylori eradication in a clinical setting success rates and the effect on the quality of life in peptic ulcer . Aliment Pharmacol Ther. 9:1995;483-490.
18. Boyd E.J.S. The prevalence of oesophagitis in patients with duodenal ulcer or ulcer-like dyspepsia. Am J Gastroenterol. 91:1996;1539-1543.
19. Csendes A., Oster M., Moller J.T., et al. Gastro-oesophageal reflux in duodenal ulcer patients before and after vagotomy. Ann Surg. 188:1978;804-808.
20. Flook D., Stoddard D.J. Gastro-oesophageal reflux and oesophagitis before and after vagotomy for duodenal ulcer. Br J Surg. 72:1985;804-807.
21. Bateson M.C., Bouchier I.A.D. The association of oesophagitis with disease of the stomach and duodenum. Postgrad Med J. 57:1981;217-218.
22. O'Connor H.J., McGee C., Mehana N., et al. Prevalence of gastro-oesophageal reflux disease (GORD) in H. pylori-positive peptic ulcer disease and the impact of eradication therapy. Endoscopy. 29:1997;E15. (abstract).
23. Laine L., Hopkins R.J., Girardi L.S. Has the impact of Helicobacter pylori therapy on ulcer recurrence in the United States been overstated? Am J Gastroenterol. 93:1998;1409-1415.
24. Bytzer P., Hansen J.M., Havelund T., et al. Predicting endoscopic diagnosis in the dyspeptic patient the value of clinical judgement . Eur J Gastroenterol Hepatol. 8:1996;359-363.
25. Bytzer P., Moller Hansen J., Schaffalitzky de Muckadell B., et al. Predicting endoscopic diagnosis in the dyspeptic patient. Scand J Gastroenterol. 32:1997;118-125.
26. Klauser A.G., Schindlbeck N.E., Muller-Lissner S.A. Symptoms in gastro-oesophageal reflux disease. Lancet. 335:1990;205-208.
27. Joelsson B., Johnsson F. Heartburn - The acid test. Gut. 30:1989;1523-1525.
28. Labenz J., Blum A.L., Bayerdorffer E., et al. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology. 112:1997;1442-1447.
29. Odman B., Lindberg G., Befrits R., et al. Stockholm Study Group for Helicobacter Infection. Gastroenterology. 114:1998;A245. (abstract).
30. Malfertheiner P., Veldhuyzen van Zanten S., Dent J., et al. Does cure of Helicobacter pylori infection induce heartburn? Gastroenterology. 114:1998;A212. (abstract).
31. Manes G., Mosca S., Laccetti M., et al. Helicobacter pylori infection, pattern of gastritis and symptoms in erosive and nonerosive gastroesophageal reflux disease. Scand J Gastroenterol. 34:1999;658-662.
32. Gillen D., Wirz A.A., Ardill J.E., et al. Rebound hypersecretion after omeprazole and its relation to on-treatment acid suppression and Helicobacter pylori status. Gastroenterology. 116:1999;239-247.